Macarena Orejudo Selected Research

Vascular System Injuries

1/2022

CCN2 (Cellular Communication Network Factor 2) Deletion Alters Vascular Integrity and Function Predisposing to Aneurysm Formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Macarena Orejudo Research Topics

Disease

7	Inflammation (Inflammations) 12/2022 - 07/2013
3	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021 - 01/2019
3	Nephrosclerosis 05/2021 - 01/2019
3	Hypertension (High Blood Pressure) 05/2021 - 01/2019
2	Albuminuria 11/2021 - 01/2019
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2015
1	Crohn Disease (Crohn's Disease) 10/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2023
1	Atherosclerotic Plaque (Atheroma) 12/2022
1	Hyperglycemia 12/2022
1	Atherosclerosis 12/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2022
1	Aneurysm (Aneurysms) 01/2022
1	Vascular System Injuries 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Vascular Remodeling 01/2020
1	Hypertrophy 01/2020
1	Disease Progression 01/2019
1	Chronic Renal Insufficiency 09/2018
1	Glomerulonephritis 08/2014
1	Fibrosis (Cirrhosis) 08/2014
1	Chronic Disease (Chronic Diseases) 07/2013

Drug/Important Bio-Agent (IBA)

8	Interleukin-17 (Interleukin 17)IBA 05/2021 - 08/2014
4	CytokinesIBA 01/2021 - 01/2019
2	FlavonoidsIBA 12/2022 - 11/2021
2	hidrosmin (F 117)IBA 12/2022 - 11/2021
2	SodiumIBA 05/2021 - 05/2021
2	Neutralizing AntibodiesIBA 05/2021 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 09/2018 - 07/2013
1	Long Noncoding RNAIBA 10/2023
1	golimumab FDA Link 10/2023
1	Ustekinumab (CNTO 1275)FDA Link 10/2023
1	Leptin ReceptorsIBA 12/2022
1	Oxidants (Oxidizing Agents)IBA 12/2022
1	Streptozocin (Streptozotocin)FDA Link 12/2022
1	LipidsIBA 12/2022
1	ApolipoproteinsIBA 12/2022
1	AldosteroneIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	AlbuminsIBA 11/2021
1	CreatinineIBA 11/2021
1	AntibodiesIBA 05/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2015
1	Connective Tissue Growth FactorIBA 01/2015

Therapy/Procedure

1	Biological Therapy 10/2023
1	Oral Administration 11/2021
1	Therapeutics 01/2020
1	Kidney Transplantation 01/2020
1	Peritoneal Dialysis 08/2014